5NX1: Combinatorial Engineering Of Proteolytically Resistant Appi That Selectively Inhibit Human Kallikrein 6 For Cancer Ther
reference: A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering., Sananes A, Cohen I, Shahar A, Hockla A, De Vita E, Miller AK, Radisky ES, Papo N, J Biol Chem. 2018 Aug 17;293(33):12663-12680. doi: 10.1074/jbc.RA117.000871. Epub, 2018 Jun 22. PMID: 29934309

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).